David A. Siegel Opgen Inc Transaction History

Two Sigma Advisers, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.12 - $62.0 $120 - $62,000	1,000 Added 3.03%	34,000 $4,000
Q3 2022 Nov 14, 2022	SELL	$0.39 - $78.8 $585 - $118,200	-1,500 Reduced 4.35%	33,000 $9,000
Q2 2022 Aug 15, 2022	BUY	$0.32 - $0.79 $256 - $632	800 Added 2.37%	34,500 $19,000
Q1 2022 May 16, 2022	BUY	$0.72 - $1.11 $2,664 - $4,107	3,700 Added 12.33%	33,700 $25,000
Q4 2021 Feb 14, 2022	BUY	$1.0 - $2.94 $30,000 - $88,200	30,000 New	30,000 $30,000

Ticker OPGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,698,500
Market Cap $38.7M
Description
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.